Hot topics close

AstraZeneca

Global Gastrointestinal Market 2021 Key Players and Growth Factor Analysis by 2027 | AstraZenec, Sanofi, Bayer ...
75
  • Global Gastrointestinal Market 2021 Key Players and Growth Factor Analysis by 2027 | AstraZenec, Sanofi, Bayer ...
  • Tenacity pays off for people eager for AstraZeneca slots
  • Selumetinib recommended for approval in EU by CHMP as first medicine for paediatric patients with neurofibromatosis ...
  • 'It's a mess': Victoria cancels under-50s vaccines after AstraZeneca call
  • Australia secures 20 million more doses of Pfizer vaccine
  • Explainer: What you need to know about the AstraZeneca advice change
  • October vaccine hopes all but over after AstraZeneca blood clot concerns prompt rollout shake-up
  • What we know so far about blood clots linked to AstraZeneca vaccine
  • ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
  • AstraZeneca vaccine rollout: People under 50 shouldn't receive AstraZeneca unless 'benefit outweighs risk'
  • AstraZeneca blood clot cases force major vaccine shake-up; Pfizer now preferred for under-50s
  • AstraZeneca COVID-19 vaccine blood clotting cause still 'unknown'. But the maths is simple
  • UK finds 30 AstraZeneca vaccine blood clot cases
  • UK finds 30 AstraZeneca blood clot cases
  • Seven UK recipients of Oxford jab reported dead after clotting
  • What we know about AstraZeneca blood clot reports
  • newsGP - Fears AstraZeneca pause in Europe could give rise to vaccine hesitancy
  • AstraZeneca vaccine rollout to continue despite overseas suspensions
  • AstraZeneca keeps backing of Australian politicians and health advisors despite blood clot concerns
  • Germany, Italy, France and Spain suspend AstraZeneca vaccine rollout amid blood clot concerns